Mylan Pharmaceuticals Inc. has recalled three lots of Prasugrel Tablets (5 mg), a prescription medication used to prevent blood clots. The recall was issued because testing showed the tablets failed dissolution specifications, meaning the medicine may not dissolve properly in the body. If the drug does not dissolve at the required rate, it may not be fully absorbed, which could reduce its effectiveness in preventing serious cardiovascular events.
If the medication fails to dissolve and absorb correctly, patients may not receive the intended dose to prevent blood clots. This could lead to a higher risk of heart attack, stroke, or other serious blood-clotting issues in patients with heart conditions.
You have 2 options:
Rx only medication.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.